Cogentis Therapeutics is a company that develops therapeutics to prevent neurodegeneration and restore brain function. It focuses on neurodegenerative disorders such as Alzheimer's disease, frontotemporal dementia (FTD), progressive supranuclear palsy (PSP), Parkinson's disease, etc.